| [1] |
LI Shunan, ZHANG Shiyan, DENG Yanan, HU Danqing, ZHENG Yuxin, LI Danyang, LI Candong.
An Analysis of Trends and Prediction of Disease Burden for Type 2 Diabetic Nephropathy from 1990 to 2021 in China
[J]. Chinese General Practice, 2025, 28(33): 4214-4226.
|
| [2] |
ZHANG Ruimin, DONG Zheyi, LI Shuang, WANG Qian, CHEN Xiangmei.
Traditional Chinese Medicine Factors Associated with Diabetic Nephropathy Diagnosed by Renal Biopsy
[J]. Chinese General Practice, 2025, 28(26): 3307-3313.
|
| [3] |
ADILI Tuersun, CHENG Gang.
Meta-analysis of the Efficacy and Safety of Finerenone in the Treatment of Type 2 Diabetic Nephropathy
[J]. Chinese General Practice, 2025, 28(21): 2686-2691.
|
| [4] |
CHANG Yupeng, GENG Xixi, HUO Rui, SUN Kan, CHANG Xiangyun, LI Jun, ZHU Lingyun, DONG Yujie, LUO Lina.
Construction and Verification the Nomogram Prediction Model for Primary Aldosteronism Based on Glomerular Filtration Rate
[J]. Chinese General Practice, 2024, 27(12): 1480-1486.
|
| [5] |
HAN Junjie, WU Di, CHEN Zhisheng, XIAO Yang, SEN Gan.
A Nomogram Prediction Model and Validation Study on the Risk of Complicated Diabetic Nephropathy in Type 2 Diabetes Patients
[J]. Chinese General Practice, 2024, 27(09): 1054-1061.
|
| [6] |
ZOU Qiong, WU Xi, ZHANG Yang, WAN Yi, CHEN Changsheng.
Prediction of Type 2 Diabetic Nephropathy Based on BP Neural Network Optimized by Sparrow Search Algorithm
[J]. Chinese General Practice, 2024, 27(08): 961-970.
|
| [7] |
DENG Yuxuan, HUANG Xuejun, JIANG Yanxia.
Recent Advances of Metformin in Treatment of Diabetic Nephropathy
[J]. Chinese General Practice, 2024, 27(03): 262-267.
|
| [8] |
ZHANG Peng, GAO Ying, YANG Hongxi, WAN Chunxiao.
Association between Serum Uric Acid Level and the Risk of Chronic Kidney Disease among the Elderly in Longevity Areas of China
[J]. Chinese General Practice, 2023, 26(31): 3884-3889.
|
| [9] |
ZHAO Lizhen, LI Weimin, JIANG Ruixia.
Clinical Value of Systemic Immune-inflammation Index in the Diagnosis of Diabetic Kidney Disease in Community-dwelling Elderly Patients with Type 2 Diabetes
[J]. Chinese General Practice, 2023, 26(18): 2227-2231.
|
| [10] |
SHU Tao, GUO Zheng, WANG Fei, CHEN Shuyan.
Analysis of the Correlation between Time in Range and Diabetic Kidney Disease
[J]. Chinese General Practice, 2023, 26(15): 1873-1879.
|
| [11] |
YAN Peng, SONG Jianling, FANG Xiangdong.
Recent Developments in Parathyroid Hormone Type 1 Receptor and Kidney Disease
[J]. Chinese General Practice, 2023, 26(11): 1398-1403.
|
| [12] |
SHEN Fei, JIANG Weiping, MEI Xiaobin, HAN Yiping, ZHAO Jiayi, FAN Jian, GU Juan, SHEN Yanhong, XU Hongmei, ZHANG Dan, MEN Ying, DING Haiguang, CHEN Caiping, HAN Junhua.
Influence of Microbiota-modulating Agents on Gut Flora in Community Patients with Diabetic Nephropathy
[J]. Chinese General Practice, 2023, 26(09): 1112-1117.
|
| [13] |
LIU Linhua, ZHAN Jinfeng, XIA Zhongbin.
Effect of Impaired Fasting Glucose on Estimated Glomerular Filtration Rate
[J]. Chinese General Practice, 2023, 26(03): 304-307.
|
| [14] |
Yujie WANG, Jian WANG, Jingwei ZHOU.
Effect of Qingre Xiaozheng Formula on Improving Renal Injury in a Rat Model of Diabetic Kidney Disease
[J]. Chinese General Practice, 2022, 25(29): 3678-3685.
|
| [15] |
Hanwen YANG, Yaoxian WANG, Qiaoru WU, Jiale ZHANG, Runze YAN, Xiaona WANG, Zhen WANG, Weiwei SUN.
Efficacy and Safety of Xiezhuoxiaozheng Therapy in Diabetic Kidney Disease: a Clinical Study
[J]. Chinese General Practice, 2022, 25(26): 3252-3257.
|